Envista Holdings (NVST) Cash from Investing Activities (2018 - 2026)
Envista Holdings (NVST) posted quarterly Cash from Investing Activities of -$68.9 million for Q2 2026, down 682.95% year-over-year from $11.8 million in Q2 2025, and down 344.52% quarter-over-quarter from -$15.5 million in Q4 2025.
Envista Holdings (NVST) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Envista Holdings' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$68.9 million for Q2 2026.
- In Q2 2026, Cash from Investing Activities fell 682.95% year-over-year to -$68.9 million; the TTM figure through Apr 2026 stood at -$111.2 million (down 111.01% YoY), while the FY2025 annual figure was -$51.1 million, up 6.41% from the prior year.
- Cash from Investing Activities for Q2 2026 stood at -$68.9 million, down from -$15.5 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $5.1 million in Q2 2022, with the low at -$591.6 million in Q3 2022.
- The 5-year median for Cash from Investing Activities is -$12.6 million (2023), against an average of -$52.6 million.
- Peak annual rise in Cash from Investing Activities reached 192.73% in 2022, while the deepest fall reached 3319.65% in 2022.
- Envista Holdings' Cash from Investing Activities stood at -$1.1 million in 2022, then tumbled by 1045.45% to -$12.6 million in 2023, then soared by 41.27% to -$7.4 million in 2024, then plunged by 109.46% to -$15.5 million in 2025, then tumbled by 344.52% to -$68.9 million in 2026.
- Business Quant data shows NVST's Cash from Investing Activities at -$68.9 million in Q2 2026, -$15.5 million in Q4 2025, and -$9.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Envista Holdings | 4.40 Bn | 3.27 Bn | 407.00 Mn | -14.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | -14.30 Mn |
| Jul 3, 2026 | -14.30 Mn |
| Apr 3, 2026 | -68.90 Mn |
| Apr 3, 2026 | -68.90 Mn |
| Dec 31, 2025 | -15.50 Mn |
| Dec 31, 2025 | -15.50 Mn |
| Sep 26, 2025 | -9.70 Mn |
| Sep 26, 2025 | -9.70 Mn |
| Jun 27, 2025 | -17.10 Mn |
| Jun 27, 2025 | -17.10 Mn |
| Mar 28, 2025 | -8.80 Mn |
| Mar 28, 2025 | -8.80 Mn |
| Dec 31, 2024 | -7.40 Mn |
| Dec 31, 2024 | -7.40 Mn |
| Sep 27, 2024 | -30.60 Mn |
| Sep 27, 2024 | -30.60 Mn |
| Jun 28, 2024 | -5.90 Mn |
| Jun 28, 2024 | -5.90 Mn |
| Mar 29, 2024 | -10.70 Mn |
| Mar 29, 2024 | -10.70 Mn |